UMass Medical School is leading the charge to better train medical and advanced practice nursing students in the prevention and management of opioid abuse, according to an Associated Press story published June 28.
Stephen C. Miller, PhD, associate professor of biochemistry & molecular pharmacology, received a 2016 McKnight Technological Innovations in Neuroscience Award for his work overcoming barriers to imaging in the brain.
Elinor Karlsson, PhD, has enrolled nearly 7,000 dog owners to provide information about their pets, as well as saliva samples, for the Darwin’s Dogs project. Researchers believe the data will help them better understand how the human genome stores and passes on inherited traits.
This year’s Summer Enrichment Program for college undergraduates welcomed 20 high-performing students who learned what it takes to gain entry to medical school.
Shan Lu, MD, PhD, has received $17.3 million from the National Institute of Allergy and Infectious Diseases to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials.
UMMS scientists have performed the first CRISPR/Cas9 screen to discover human proteins that Zika virus needs for replication. This work, led by Abraham Brass, MD, PhD, reveals new leads that may be useful for halting Zika, dengue and other emerging viral infections.
In this Women In Science video, MD/PhD student Miriam Madsen talks about her PhD project to develop technologies that improve quality of life and bolster independence for people with temporary or chronic physical and neurodevelopmental disabilities.
Cancer survivor Liam Fitzgerald, 10, otherwise known as the “Fist-bump Kid,” stole the show at the June 16 breakfast to kick off the campaign for the 18th annual UMass Medicine Cancer Walk/Run. The event is Sept. 25.
School of Medicine student Nitin Shrivastava belongs to an international consortium of researchers and clinicians working in Guatemala to test and disseminate use of a free smartphone app that detects leukocoria and increases early diagnosis of retinoblastoma.
Patrick Emery, PhD, received a $4.1 million MIRA award from the National Institute of General Medical Sciences to study the molecular, genetic and neural mechanisms underlying circadian rhythms and their synchronization by environmental clues such as light and temperature cycles.